An investigation into the immunomodulating effects of Andrographis paniculata in healthy males
Not Applicable
Completed
- Conditions
- Immune function in healthy population
- Registration Number
- ACTRN12617000186358
- Lead Sponsor
- Integria Healthcare (Australia) Pty Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Andrographis paniculata modulate immune function in healthy males?
How does Andrographis paniculata compare to standard immune-boosting therapies in clinical trials?
Are there specific biomarkers that predict immunomodulatory response to Andrographis paniculata in healthy populations?
What are the known or potential adverse events associated with Andrographis paniculata supplementation in healthy males?
What related compounds or combination therapies are being explored for immune modulation alongside Andrographis paniculata?